Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...

The U.S. Food and Drug Administration approved a new non-opioid pain medication developed by the Massachusetts-based company ...

Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

VRTX insiders have traded $VRTX stock on the open market 11 times in the past 6 months. Of those trades, 0 have been purchases and 11 have been sales. Here’s a ...

PROVIDENCE, R.I. (WPRI) — The Rhode Island State Police have fired two troopers who posted a video on social media of 21-year-old Alex Montesino getting hit and killed by a car on I-95 in October.

Get Pro-Level Earnings Insights Before the Market Moves In a court filing on Monday, the Department of Health and Human Services (HHS) challenged Vertex Pharmaceuticals Inc VRTX, defending its ...

Vertex Pharmaceuticals' current market capitalization, exceeding $108 billion as of January 15, 2025, reflects strong investor confidence in its established cystic fibrosis (CF) franchise and its ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Vertex Pharmaceuticals wasn’t one of them. The 10 stocks that ...

Keith Speights has positions in Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Vertex Pharmaceuticals. The Motley Fool has a disclosure policy. Why This Beaten-Down Growth ...

The most recent trading session ended with Vertex Pharmaceuticals (VRTX) standing at $416.96, reflecting a -1.72% shift from the previouse trading day's closing. The stock's performance was behind ...